Verona Pharma Plc ADR
(VRNA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2021 | 06-2021 | 03-2021 | 12-2020 | 09-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 166,547 | 146,035 | 169,598 | 187,986 | 201,968 |
| Receivables | 10,606 | 54,110 | 10,272 | 8,260 | 5,838 |
| Other current assets | 667 | 6,321 | 1,484 | 1,720 | 0 |
| TOTAL | $184,492 | $216,283 | $188,601 | $202,504 | $212,474 |
| Non-Current Assets | |||||
| PPE Net | 88 | 89 | 98 | 107 | 107 |
| Intangibles | 545 | 545 | 545 | 545 | 32,052 |
| Other Non-Current Assets | 16,435 | 1,585 | 906 | 1,050 | 1,194 |
| TOTAL | $17,068 | $2,219 | $1,549 | $1,702 | $33,353 |
| Total Assets | $201,560 | $218,502 | $190,150 | $204,206 | $245,827 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 9 | 34 | 541 | 178 | 14,194 |
| Accrued Expenses | 26,457 | 17,188 | 8,514 | 10,863 | N/A |
| Other current liabilities | 187 | 342 | 2,886 | 2,364 | 1,857 |
| TOTAL | $27,740 | $58,364 | $12,698 | $14,203 | $16,859 |
| Non-Current Liabilities | |||||
| Long Term Debt | 4,821 | 4,767 | 4,685 | 4,635 | N/A |
| Deferred Revenues | N/A | 40,051 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 30,552 |
| TOTAL | $5,618 | $5,741 | $5,038 | $5,149 | $31,253 |
| Total Liabilities | $33,358 | $64,105 | $17,736 | $19,352 | $48,112 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 60,010 | 60,036 | 57,968 | N/A | N/A |
| Common Shares | 31,855 | 31,824 | 31,794 | 31,794 | 30,054 |
| Retained earnings | -240,287 | -251,265 | -228,370 | -207,050 | -180,041 |
| Other shareholders' equity | -4,371 | -4,444 | -4,271 | -4,301 | 17,634 |
| TOTAL | $168,202 | $154,397 | $172,414 | $184,854 | $197,715 |
| Total Liabilities And Equity | $201,560 | $218,502 | $190,150 | $204,206 | $245,827 |